MARKET

NUVA

NUVA

NuVasive
NASDAQ

Real-time Quotes | Nasdaq Last Sale

68.49
+0.06
+0.09%
After Hours: 68.49 0 0.00% 17:00 04/13 EDT
OPEN
68.29
PREV CLOSE
68.43
HIGH
69.00
LOW
67.41
VOLUME
284.69K
TURNOVER
--
52 WEEK HIGH
69.28
52 WEEK LOW
43.11
MARKET CAP
3.52B
P/E (TTM)
-93.6295
1D
5D
1M
3M
1Y
5Y
Spinal Non-Fusion Devices Market Size 2018 Driving Factors, Industry Growth, Key Vendors and Forecasts to 2026
Apr 12, 2021 (Market Insight Reports) -- Selbyville, Delaware Market Study Report LLC adds new research on Spinal Non-Fusion Devices market, which is a...
Market Insight Reports · 1d ago
Spinal Trauma Devices Market 2021 Latest Report Covering Key vendors, Price Trends, Gross Margin, Influence of COVID-19 and Forecast To 2026
Apr 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Spinal Trauma Devices Market” has...
The Express Wire · 1d ago
Orthopedic Biomaterials Market Expects CAGR of Close to 9.83% By 2027
Apr 12, 2021 (Market Insight Reports) -- The Orthopedic Biomaterials Market size is forecast to exceed US$ 26.5 billion by 2027 and the Orthopedic...
Market Insight Reports · 1d ago
Orthobiologics Market to Register Stunning Growth by 2031 | Players: Medtronic plc and NuVasive Inc.
Apr 12, 2021 (WiredRelease via Comtex) -- Market.us adopted a multidisciplinary detain during the pandemic-era to focus on the revolutionary trends, growth...
marketresearch.biz · 1d ago
Human Embryonic Stem Cells Market 2021 Size, Growth, Share, Global Industry Current Trends, Analysis of Top Companies, Application, Development and Forecast to 2025 Research Report
Apr 11, 2021 (The Expresswire) -- Global “ Human Embryonic Stem Cells Market” report provides a detailed analysis of global size, share, regional and...
The Express Wire · 3d ago
Cell Therapy Market projected to reach US$ 12,563.23 million by 2027 and to grow at a CAGR of 7.2%
Apr 09, 2021 (AB Digital via COMTEX) -- According to our new market research study on “Cell Therapy Market Forecast to 2027 – COVID-19 Impact and...
ABNewswire · 4d ago
Spinal Fusion Market Size, Industry Report by Share, Growth, Key Regions, Segments, Trends, Technology and Forecast till 2028
Apr 09, 2021 (Heraldkeepers) -- The scope of the report includes a detailed study of Spinal Fusion Market with the reasons given for variations in the growth...
Heraldkeepers · 4d ago
Spinal Implants Market 2021 Global Technology, Development, Industry Share, Size, Growth, Trends and COVID-19 Impact Analysis 2027
Apr 09, 2021 (Heraldkeepers) -- The Global Spinal Implants Market is expected to exceed more than US$ 19.5 Billion by 2024 at a CAGR of 7% in the given...
Heraldkeepers · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NUVA. Analyze the recent business situations of NuVasive through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NUVA stock price target is 66.19 with a high estimate of 81.00 and a low estimate of 52.00.
EPS
Institutional Holdings
Institutions: 452
Institutional Holdings: 56.56M
% Owned: 110.08%
Shares Outstanding: 51.38M
TypeInstitutionsShares
Increased
77
3.90M
New
52
2.05M
Decreased
111
6.23M
Sold Out
33
1.43M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.85%
Healthcare Equipment & Supplies
+1.78%
Key Executives
Chairman/Director
Gregory Lucier
Chief Executive Officer/Director
J. Christopher Barry
Chief Financial Officer/Executive Vice President
Matthew Harbaugh
Chief Human Resource Officer
Lucas Vitale
Executive Vice President
Brent Boucher
Executive Vice President
Massimo Calafiore
Senior Vice President/General Counsel/Secretary
Nathaniel Sisitsky
Senior Vice President
Dale Wolf
Independent Director
Vickie Capps
Independent Director
John DeFord
Independent Director
Robert Friel
Independent Director
R. Scott Huennekens
Independent Director
Siddhartha Kadia
Independent Director
Leslie Norwalk
Independent Director
Donald Rosenberg
Independent Director
Daniel Wolterman
No Data
About NUVA
Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.

Webull offers kinds of NuVasive, Inc. stock information, including NASDAQ:NUVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUVA stock methods without spending real money on the virtual paper trading platform.